John D Catravas Selected Research

John D Catravas Research Topics

Disease

17	Lung Injury 02/2024 - 10/2004
13	Inflammation (Inflammations) 12/2022 - 10/2007
11	Pulmonary Fibrosis (Fibrosing Alveolitis) 02/2024 - 01/2019
9	Acute Lung Injury 01/2022 - 05/2010
6	Fibrosis (Cirrhosis) 01/2022 - 01/2019
5	Asthma (Bronchial Asthma) 01/2022 - 03/2005
5	Sepsis (Septicemia) 11/2020 - 09/2007
4	Body Weight (Weight, Body) 01/2022 - 10/2007
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 02/2002
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2023 - 01/2021
3	Neoplasms (Cancer) 05/2020 - 06/2013
3	Pulmonary Hypertension 01/2019 - 02/2002
3	Pneumonia (Pneumonitis) 12/2016 - 10/2007
3	Edema (Dropsy) 10/2012 - 10/2008
2	COVID-19 01/2023 - 01/2020
2	Idiopathic Pulmonary Fibrosis 01/2022 - 07/2020
2	Hypoxia (Hypoxemia) 10/2008 - 02/2002
1	Pulmonary Arterial Hypertension 08/2022
1	Alcoholism (Alcohol Abuse) 01/2022
1	Cytokine Release Syndrome 01/2022
1	Disease Progression 01/2022
1	Obesity 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Lung Diseases (Lung Disease) 05/2020
1	Airway Obstruction (Choking) 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 02/2018
1	Familial Primary Pulmonary Hypertension 01/2015
1	Vascular Remodeling 08/2014
1	Right Ventricular Hypertrophy 08/2014
1	Pneumococcal Pneumonia 10/2012

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2007
10	Heat-Shock Proteins (Heat-Shock Protein)IBA 02/2024 - 10/2007
9	Hydrochloric Acid (Hydrogen Chloride)FDA Link 02/2024 - 01/2019
5	CollagenIBA 01/2022 - 01/2020
4	CytokinesIBA 12/2022 - 10/2007
4	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2019
4	Estrogens (Estrogen)FDA Link 10/2021 - 02/2002
3	Mechlorethamine (Nitrogen Mustard)FDA Link 05/2021 - 01/2020
3	LipopolysaccharidesIBA 01/2017 - 02/2014
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017 - 11/2006
3	EndotoxinsIBA 12/2016 - 10/2007
2	TAS-116IBA 02/2024 - 01/2022
2	ChemokinesIBA 12/2022 - 10/2007
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2022 - 10/2012
2	Vasodilator Agents (Vasodilators)IBA 08/2022 - 01/2015
2	SARS-CoV-2 spike proteinIBA 01/2022 - 01/2021
2	InflammasomesIBA 01/2022 - 01/2022
2	Methacholine Chloride (Methacholine)FDA Link 01/2022 - 03/2009
2	Extracellular Matrix ProteinsIBA 07/2020 - 05/2020
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2020 - 11/2017
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 02/2018 - 12/2016
2	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2017 - 05/2010
2	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2014 - 11/2005
2	Nitric Oxide Synthase (NO Synthase)IBA 05/2010 - 11/2006
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 04/2008 - 10/2004
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 10/2007 - 02/2002
1	AcetoneIBA 02/2024
1	Gefitinib (Iressa)FDA Link 02/2024
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2024
1	Ethanol (Ethyl Alcohol)IBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	ElastinIBA 01/2022
1	(2,4- dihydroxy- 5- isopropylphenyl)- (5- (4- methylpiperazin- 1- ylmethyl)- 1,3- dihydroisoindol- 2- yl)methanoneIBA 01/2022
1	Fibronectins (Fibronectin)IBA 01/2022
1	nintedanibIBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	pirfenidoneIBA 01/2022
1	LipidsIBA 01/2022
1	A-factor (Streptomyces)IBA 01/2022
1	Estrogen ReceptorsIBA 10/2021
1	Phytoestrogens (Phytoestrogen)IBA 10/2021
1	GenisteinIBA 10/2021
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2021
1	ActomyosinIBA 01/2021
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 11/2020
1	ProteomeIBA 07/2020
1	AcidsIBA 05/2020
1	AntidotesIBA 05/2020
1	remdesivirIBA 01/2020
1	QuercetinIBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	Interleukin-2 (IL2)IBA 01/2019
1	Hydroxyproline (4 Hydroxyproline)IBA 01/2019
1	Oncogene Proteins (Oncogene Protein)IBA 02/2018
1	Protein Tyrosine PhosphatasesIBA 02/2018
1	JMS-053IBA 02/2018
1	Therapeutic UsesIBA 11/2017
1	Thiamine (Aneurin)FDA Link 11/2017
1	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2017
1	ezrinIBA 12/2016
1	moesinIBA 12/2016
1	Histone Deacetylase InhibitorsIBA 12/2015
1	NADPH Oxidase 4IBA 08/2014
1	MonocrotalineIBA 08/2014
1	dimethylargininaseIBA 03/2014
1	Virulence Factors (Pathogenicity Factors)IBA 10/2012
1	Streptococcus pneumoniae plY proteinIBA 10/2012
1	Transforming Growth Factor beta (TGF-beta)IBA 02/2012

Therapy/Procedure

4	Therapeutics 01/2023 - 01/2019
2	Estrogen Replacement Therapy 03/2009 - 02/2002